Clinical Trial Update: Efficacy and Safety of DA-3002 in Short Children Borns SGA. [Phase 3]

View source ↗

Summary

Phase 3 trial update on DA-3002 evaluating efficacy and safety in infants born small for gestational age has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infant Small For Gestational Age

Drugs mentioned

• DA-3002

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Infant, Small for Gestational Age | Phase 3 | Status: COMPLETED